3645 results for «715»

Filter By

3645 results

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

05 Oct 2024 – From AICT-AsiaPCR 2024

A 40-year-old male with no comorbidities presented an NSTEMI. The angiography showed a focus lesion on the mid-CX and a diffuse lesion on the mid and distal LAD. The LAD FFR are 0.49 with a diffuse pullback gradient.
After Stent in mid-CX guided by OCT, the operators...

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

Complications in women: crash and burn or crash and save

05 Oct 2024 – From AICT-AsiaPCR 2024

Complications can arise even in the most experienced hands. This session explores a series of challenging cases involving women, from a detached mitral clip to a calcified vessel perforation. Witness the crash and burn moments, but also the heroic crash and save interventions, as our experts...

Complications in women: crash and burn or crash and save

Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms

05 Oct 2024 – From AICT-AsiaPCR 2024

Prepare to be captivated by a collection of intriguing STEMI cases, curated from the AICT-AsiaPCR 2024 submissions. From a left main PCI in a patient with dextrocardia to a challenging case of primary PCI in an aneurysmal coronary artery, this session promises to push the boundaries...

Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms

How should I treat complex lesion from the intracoronary imaging view?

05 Oct 2024 – From AICT-AsiaPCR 2024

Intracoronary imaging plays a crucial role in guiding treatment strategies for complex lesions. This session delves into the use of various imaging modalities, such as IVUS and OCT, to optimize PCI outcomes. Explore real-world case examples, including a sudden coronary arrest caused by focal stenosis with...

How should I treat complex lesion from the intracoronary imaging view?

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD
Didn’t find what you were looking for?